Stay updated on Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces an update to terminology used across NIH content. The ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:13:45.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T22:37:21.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error page with a minimal header and a Home button. This indicates access restrictions rather than changes to the study content.
    Difference
    0.5%
    Check dated 2026-09-29T22:33:46.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error for the study record, replacing the usual content with a standard error screen and a Home button. This indicates the page content is temporarily unavailable due to access restrictions.
    Difference
    20%
    Check dated 2026-09-23T00:22:47.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.6 to v3.7.0, indicating a deployment of a newer version of the page or site template. This change appears to be a metadata update rather than a modification to the study content.
    Difference
    0.1%
    Check dated 2026-09-15T23:42:33.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a minor site/build update.
    Difference
    0.1%
    Check dated 2026-09-01T19:12:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.